Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better. 

From the week of the 13th of January, we are planning to work on 16 projects, including: 

Reimbursement 

  1. Delivering policy analysis project, including qualitative interviews, in the obstetrics and gynecology field in Austria, Denmark, Finland, Norway and Sweden  

  2. Delivering market access strategy for parenteral drug delivery systems in outpatient specialist and home-based care in Austria, Belgium, Czech Republic, Denmark, England, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Spain, Sweden 

  3. Working on the reimbursement analysis for embolization procedures in different indications in England, France, Germany, Italy, and Spain 

  4. Working on the reimbursement analysis for treatment of endoleak following endovascular treatment of aortic aneurysm in England, France, Germany, and Italy 

  5. Working on reimbursement analysis for several technologies in ophthalmological, urological, and oncological fields in Belgium and the Netherlands 

  6. Working on reimbursement analysis for orthopedic technology in Belgium, Italy, the Netherlands, and Spain 

  7. Initiating work on the reimbursement analysis for remote monitoring in the cardiology field in Germany and the Netherlands 

  8. Initiating work on the reimbursement analysis for local treatment of skin disorders in England and Germany 

HEOR 

  1. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain  

  2. Finalizing the development of the reimbursement application for technology in the neurovascular field in Ireland  

  3. Working on the development of the reimbursement application for technology in the neurovascular field in Hungary  

  4. Working on the update of adaptation of the global value dossiers for several technologies in cardio-renal and infectious disease space to European settings  

  5. Working on the development of a value dossier for a urological technology in the EMEA region 

  6. Working on the systematic literature review for neurological technology 

  7. Working on the literature review for assisted reproduction technology  

  8. Initiating work on the development of an early value dossier for wound treatment technology in European countries  

Let us know if you need any market access or HEOR support for your medical technology in Europe.